Skip to main content
Back
Watch Compare

Microbot Medical Inc.

Data quality: 83%
MBOT
Nasdaq Manufacturing Measuring & Analyzing Instruments
$2.59
▲ $0.11 (4.44%)
Mkt Cap: 163.53 M
Price
$2.44
Mkt Cap
163.53 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Negative free cash flow of -13.11 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-24.21%
Above sector avg (-53.34%)
ROIC-21.33%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio27.53
Interest CoverageN/A

Valuation

PE (TTM)
-12.44
Below sector avg (-1.47)
P/B Ratio2.09
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -12.4 -1.5
P/B 2.1 1.6
ROE % -24.2 -53.3
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

Analyst Price Target

3 analysts
Buy
Current
$2.59
+189.6%
Target
$7.50
$5.00
$5.50
$12.00
Forecast
Forward P/E -7.85
Forward EPS -$0.33
Est. Revenue 9.46 M

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2027 -$0.33
-$0.34 – -$0.32
 9.46 M 2
FY2026 -$0.32
-$0.32 – -$0.32
 2.86 M 1

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q42025 -$0.06 -$0.04 +33.3%
Q32025 -$0.06 -$0.07 -16.7%
Q22025 -$0.08 -$0.10 -25.0%
Q12025 -$0.13 -$0.08 +38.5%

ETFs Holding This Stock

BRUSX BRUSX
0.25% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -13.14 M
ROE -24.21% ROA -22.88%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -13.11 M
ROIC -21.33% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 27.53
Interest Coverage N/A Asset Turnover N/A
Working Capital 77.85 M Tangible Book Value 78.22 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -12.44 Forward P/E N/A
P/B Ratio 2.09 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -8.01%
Market Cap 163.53 M Enterprise Value 156.83 M
Per Share
EPS (Diluted TTM) -0.29 Revenue / Share N/A
FCF / Share -0.20 OCF / Share -0.19
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 99.73%
SBC-Adj. FCF -14.21 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -13.14 M -11.44 M -10.74 M -13.17 M -11.31 M
EPS (Diluted) -0.29 -0.73 -1.05 — —
Gross Profit — — — — —
Operating Income -14.74 M -11.63 M -9.86 M -13.28 M -11.36 M
EBITDA — — — — —
R&D Expenses 6.28 M 6.63 M 5.72 M 7.74 M 6.15 M
SG&A Expenses 8.46 M — — — —
D&A 47,000.0 91,000.0 106,000.0 102,000.0 76,000.0
Interest Expense — — — — —
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 81.54 M 6.03 M 8.33 M 9.54 M 16.77 M
Total Liabilities 3.99 M 2.50 M 3.83 M 2.25 M 2.39 M
Shareholders' Equity 77.55 M 3.53 M 4.50 M 7.29 M 14.38 M
Total Debt — — — — —
Cash & Equivalents 3.91 M 3.11 M 2.47 M 2.44 M 13.49 M
Current Assets 79.82 M 5.82 M 7.92 M 8.81 M 15.88 M
Current Liabilities 3.42 M 2.46 M 3.79 M 2.07 M 1.98 M